Retraction
Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer
Paper Information
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9817296Additional Notes:
See also: https://pubpeer.com/publications/2CBB1F3E2257591A6571A522AC41F9
Citations (5)
5
Total Citations0
Post-Retraction4
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors
Thomas F. Cash, Hunter C. Jonus, Maya Tsvetkova et al. (10 authors)
Pediatric Blood & Cancer
Published: May 2023
6 citations
6 citations
43 days before retraction
Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy
Masanobu Tsubaki, Tomoya Takeda, Takuya Matsuda et al. (10 authors)
Cancer Cell International
Open Access
Published: Apr 2023
12 citations
12 citations
65 days before retraction
KRAS Mutations in Solid Tumors: Characteristics, Current Therapeutic Strategy, and Potential Treatment Exploration
Yunkai Yang, Huan Zhang, Shanshan Huang et al. (4 authors)
Journal of Clinical Medicine
Open Access
Published: Jan 2023
35 citations
35 citations
156 days before retraction
Retracted: Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer
Evidence-Based Complementary and Alternative Medicine
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jan 2023
171 days before retraction
Quick Stats
Total Citations:
9
Years Since Retraction:
2.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025